Product Development Policy | Research & Development | SENJU Pharmaceutica
include intractable diseases, such as Fuchs’ endothelial corneal dystrophy. The latter condition is rare in Japan and generally known as a rare disease, yet there are many patients suffering from it w...
http://www.senju.co.jp/english/rd/policy/